addresses an important and highly general health issue. The study seems to be designed well and the protocol is concise but informative. However, there are some concerns that may need attention: -setting: o there were three different paths to be eligible in the study: primary care referral, secondary care patient path and community advertisement path -these three paths are quite different from each other and therefore also the adherence, level of symptoms, other symptoms etc. of the possible participants may vary. How would the authors interpret these "subgoups" and their possible differences and results? -5. Are research ethics (e.g. participant consent, ethics approval) addressed appropriately : personally, I am not confident about the use of verbal informed consent in the recruitment phase. That would probably need some clarification and references even though the ethical approval is achieved and reported well. -what is the approximate time that is spent per participant in intervention or in the control group? According to some e.g. Cochrane reviews about Low back pain, the effectiveness of intervention depends highly on the intervention time / participant -4. Is the study design appropriate to answer the research question : the intervention is multiphasic, complex and very comprehensive package o it might be challenging to determine, what would be the most effective part of the intervention, especially when, probably, several participants will not take part in the intervention procedure as a whole. The methods part of the protocol may need some clarification on that. Reviewer 1 Comment 1: To date, there is no evidence that inadequate consumption of fruit and vegetable increases low back pain chronicity and disability. Author response: We are assuming this comment is in relation to the eligibility criteria. Poor diet may increase low back pain chronicity and disability either directly via inflammatory processes or indirectly through weight and emotions. Because healthy eating is an intervention target, irrespective of participant body weight, fruit and vegetable consumption will be used as a proxy measure of overall diet quality for quickly assessing eligibility during the screening process. To make this clearer in the manuscript we have added words in track changes to clarify under the "Eligibility" section on page 6.
Reviewer 1 Comment 2: No information on exposure to physical workload factors will be gathered at baseline. The effectiveness of lifestyle interventions may differ between patients with and without exposure to physical workload factors. While it is possible that physical workload factors are associated with outcome, we have no strong evidence that they are treatment effect modifiers for the interventions under investigation in the trial. Given the sample size and randomisation we have no reason to expect an imbalance between groups in the case that it is a confounder.
Reviewer 1 Comment 3: Data will be collected at baseline, and weeks 6, 12, 26 and 52, but only data on disability at 26 weeks will be utilized for the primary outcome. Data collected at weeks 6 and 12 should also be used. Author Response: Primary analysis will use data from baseline, 6, 12 and 26 weeks in a linear mixed effects regression model, this will provide an estimate effect over 26 weeks of follow-up, rather than at 26 weeks. This is outlined on page 20: "A linear mixed effects regression model will be used to estimate the effectiveness of the intervention in reducing self-reported disability compared to control over 26 weeks of follow-up."
Reviewer 1 Comment 4: Will change in BMI or weight during the follow-up period be considered as an outcome? Author response: Weight is pre-specified as a key secondary outcome as per Table 3 and in the outcomes section page 16. We will report weight, as well as a change in weight from baseline to all follow-up time points between groups in the primary outcome paper.
Reviewer 1 Comment 5: Will quitting smoking during the follow-up period be the outcome? The success of quitting smoking is very low. Would you also consider reducing the number of cigarettes smoked per day? How long should quitting smoking last? Author response: We will collect data on the number of cigarettes smoked per day at each time point as per Table 3 . This data will be reported alongside smoking status (quit or not) as a secondary outcome.
Reviewer 1 Comment 6: There are many secondary and exploratory outcomes. The statistical significance level should be adjusted for multiple testing using Bonferroni correction. To avoid positive findings, the alpha value should be lowered. Author Response: We deliberately pre-specify four key secondary outcomes (weight, smoking, pain and quality of life) for interpretation to reduce the possibility of Type I error, therefore significance level was adjusted for these outcomes. We do not consider the number of primary (1) and secondary (4) outcomes excessive or requiring of adjustment for statistical significance, this decision was reached with consultation of our statistician. Exploratory outcomes are collected for the purposes of mediation and process analyses, as such change on these outcomes will not be interpreted as 'effects' of the intervention. • There were three different paths to be eligible in the study: primary care referral, secondary care patient path and community advertisement path -these three paths are quite different from each other and therefore also the adherence, level of symptoms, other symptoms etc. of the possible participants may vary. How would the authors interpret these "subgoups" and their possible differences and results? Author response: We acknowledge there may be differences in patients adherence, symptoms etc depending on their referral source. All patients however are randomised and we therefore expect there to be equal variation across both intervention and control groups. We do not intend to interpret outcome data based on patient referral source subgroups, however will report on the number of patients randomised from each referral source in a CONSORT statement in the outcomes paper. Are research ethics (e.g. participant consent, ethics approval) addressed appropriately? • Personally, I am not confident about the use of verbal informed consent in the recruitment phase. That would probably need some clarification and references even though the ethical approval is achieved and reported well. Author response: The procedures regarding consent and recruitment have been scrutinised and approved by two ethics committees (one university and one health service). As detailed, written consent is subsequently obtained at the first consultation. The authors contend that this process is sufficient to ensure ethical design of the study operations. Similar recruitment procedures were also used in two RCTs previously conducted by the group (Williams A et What is the approximate time that is spent per participant in intervention or in the control group? According to some e.g. Cochrane reviews about Low back pain, the effectiveness of intervention depends highly on the intervention time / participant. Author response: Participants in the intervention group will receive up to 4, 1-hour face-to-face sessions with a physiotherapist and dietician, and up to 10 phone calls from the Get Health Service. Participants in the control group will receive up to 3, 1-hour sessions with a physiotherapist. It may be that there is an imbalance in contact time with participants between group, but the study seeks to answer a pragmatic question about the effectiveness of a new intervention model versus usual care in the jurisdiction in which the study is being conducted ie. public healthcare system in Australia. Interpretation of the findings will reflect the pragmatic study design. Is the study design appropriate to answer the research question: • The intervention is multiphasic, complex and very comprehensive package so it might be challenging to determine, what would be the most effective part of the intervention, especially when, probably, several participants will not take part in the intervention procedure as a whole. The methods part of the protocol may need some clarification on that. Author response: We acknowledge the intervention is complex and there is difficulty in determining the most effective components. Hence as described in the protocol, we have planned supplementary analyses to help explore precisely this question. Causal mediation analysis will be conducted to determine treatment mechanisms by which the intervention works to effect the primary outcome. This analysis will provide insight into where aspects of the intervention may work (i.e. changes physical activity, weight), or break down in trying to improve patient back pain related disability. Additionally, Complier Average Caudal Effects (CACE) analysis will be used to consider the impact of patient adherence (dose received) to appointments and telephone support services on outcomes. If statistics are used are they appropriate and described fully? • The case of poor adherence, missing data processing and possible drop outs should be addressed more thoroughly -because of the complex nature of the intervention, confounding by indication -bias should be interpreted and handled. Author response: The impact of adherence will be explored via CACE analyses (Pg 21). In the case where missing data exceeds 10% multiple imputation models will be constructed. It is not possible to specify the exact nature of these models at this point (Pg 20). Confounding by indication will not be an issue because allocation to group is randomised and concealed (Pg 19).
Are the study limitations discussed adequately? • This may also be included in the protocol for instance, if effectiveness is gained, what is the main reason for that (what part of intervention) in such a complex and multiphasic intervention? Especially when, probably, all sessions will not be attended by the participants. Author response: This limitation will be addressed by our pre-specified CACE and mediation analyses.
• Generalization, if effectiveness is shown: is it feasible to recommend this kind of (probably costly and) complex intervention for a wider use? Author response: As stated in the protocol we intend to conduct a cost effective analysis at the conclusion of the study. This information will help inform generalisability and wider implementation if effective. Depending on cost benefit and effectiveness of certain aspects of the intervention i.e appointments, telephone support services, resources will further enable quality decision making for translation to practice. The broad inclusion criteria for patients with chronic low back pain also adds to the generalisability of the study. 
GENERAL COMMENTS
Interesting study, good luck!
